AARDVARK THERAPEUTICS, INC. Accumulated Other Comprehensive Income
AARDVARK THERAPEUTICS, INC. (AARD) had Accumulated Other Comprehensive Income of $0 as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $14.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $81.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $82.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 |
| 2026-03-31 | $14.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $81.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $82.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$3.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $44.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |